A Critical Overview on Casuarina equisetifolia

Pharmacognosy Reviews,2023,17,34,255-261.
Published:November 2023
Type:Review Article
Authors:
Author(s) affiliations:

Shashank Tiwari1,*, Shreya Talreja2

1Academics and Research, Lucknow Model College of Pharmacy, Lucknow, Uttar Pradesh, INDIA.

2Department of Pharmaceutical Chemistry, Lucknow Model College of Pharmacy, Lucknow, Uttar Pradesh, INDIA.

Abstract:

Casuarina equisetifolia is a fast-growing species and highly nutritive multipurpose, valued tree crop. It is a large, straight, attractive evergreen tree with hanging branches. The tree contains many bioactive compounds, nutritive compounds, phenolic compounds, flavonoids, Terpenes and also contain protein due to the presence of these compound the tree exhibit many biological/ Pharmacological activity and the all parts of tree such as Leaves, seed, flower, fruits and root also useful for the treatment of various diseases includes cancer treatment, GI disease and disorders, Liver diseases, etc. It is also useful for the treatment of Diabetes mellitus and possess various activity like anti-hypertensive activity, anti-arthritic activity, hypocholestraemic activity, etc. The indigenous population relied heavily on the Casuarinaceae family for the survival and the Casuarinaceae family was widely used as traditional bush medicine. Traditional medicine has long relied on plants as a safe and effective source of treatment. About 75% of people today still rely on conventional medical techniques for the treatment of a wide range of illnesses. Plants ability to serve as medicinal agents is dependent on their phytochemicals. There hasn't been enough research and study done on the pharmacological and therapeutic potential of tree species like C. equisetifolia. So, the main aim of this review was to promote or discover the knowledge about this multipurpose tree and its medicinal importance.

Cite This Article

Vancouver Style ::
S. Tiwari and Talreja, S. , A Critical Overview on Casuarina equisetifolia, Pharmacognosy Reviews, vol. 17, no. 34, pp. 255-261, 2023.